Alvarez Secord A, O'Malley DM, Sood AK, Westin SN, et al. Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A review. Gynecol Oncol 2021 Jun 2. pii: S0090-8258(21)00424.
PMID: 34090705